Sorafenib inhibits macrophage-mediated epithelial-mesenchymal transition in hepatocellular carcinoma

SUPPLEMENTARY FIGURES AND TABLE Supplementary
: The mRNA expression of pro-apoptotic genes in polarized THP1 macrophages treated or untreated with sorafenib. Sorafenib or DMSO vehicle (mock) was added to cultured cells for 3 h. This treatment was followed by a medium change and stimulation with LPS (1 ng/mL) for 24 h. Real-time PCR was performed to analyze the pro-apoptotic genes Bax, Bad, and caspase3 in polarized THP1 macrophages treated or untreated with sorafenib. Polarized macrophage culture conditions: 0, DMSO + LPS; 0.3, sorafenib (0.3 μg/mL) + LPS; 1.2, sorafenib (1.2 μg/mL) + LPS. HepG2 and HL7702 cells were collected 48 h later, and subjected to Western blot analyses ( Figure 3B) . Densitometry of the intensities of the protein band on a series of Western blots was used to quantify the levels of each protein expression. Data were presented as the expression levels relative to the GAPDH levels in each group. Data were from 3 to 4 separate experiments and presented as mean ± SD. *P < 0.05. Figure 7B ). Data were presented as the expression levels relative to the GAPDH levels in each group based on densitometry of the intensities of protein bands. Data were from 3 to 4 separate experiments and presented as mean ± SD. *P < 0.05.
